Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2006 (Vol. 26, No. 10)

The Basics of Plant Biotechnology

URL:www.monsanto.co.uk/primer/basics.html
  • Educational material, news
  • Not comprehensive enough
When it comes to plant biotechnology, it doesn’t get much bigger than Monsanto, so this is a logical place to start. The pages are organized efficiently. The Biotech Primer section provides basic educational material on biotechnology. A more interesting section for scientists is the Biotech Knowledge Center that provides mostly news, a glossary of biotechnology terms, and a Topic Library. The last section contains only five different topics, however, with each topic containing many links to articles. The focus of these is largely on the benefits of biotechnology from an industry perspective. Overall, the Monsanto site is informative but not comprehensive enough.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »